Statins ameliorate cholesterol-induced inflammation and improve AQP2 expression by inhibiting NLRP3 activation in the kidney

Background: Chronic kidney diseases (CKD) are usually associated with dyslipidemia. Statin therapy has been primarily recommended for the prevention of cardiovascular risk in patients with CKD; however, the effects of statins on kidney disease progression remain controversial. This study aims to inv...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Yonglun, Feng, Weijing, Zhao, Xiaoduo, Zhang, Puhua, Li, Suchun, Li, Zhijian, Lin, Yu, Liang, Boen, Li, Chunling, Wang, Weidong, Huang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482822/
https://www.ncbi.nlm.nih.gov/pubmed/32929357
http://dx.doi.org/10.7150/thno.49603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482822/
https://www.ncbi.nlm.nih.gov/pubmed/32929357
http://dx.doi.org/10.7150/thno.49603

Ejemplares similares